Incyte stock hit 11% despite paediatric dermatology trials hitting target
The US company’s two simultaneous trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.
Healthcare Finance News3d
Cigna teaming with Carrot on fertility access
The Global Health Benefits (GHB) business of Cigna Healthcare's International Health division is partnering with Carrot ...
Managed Healthcare Executive4d
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for ...
Fierce Healthcare4d
Cigna shuffles top leaders, elevates Evanko to COO
The Cigna Group is the latest insurer to shuffle its top leadership as it aims to turbocharge its growth strategy. | The ...
Insurer Cigna names new COO, CFO in management reshuffle
Cigna has made a series of upper management changes, which include making CFO Brian Evanko as the healthcare conglomerate's ...
Fierce Healthcare4d
Cigna's Global Health Benefits unit taps Carrot for fertility offering
Cigna's Global Health Benefits unit is teaming up with Carrot Fertility to offer personalized support to members on the ...
Le Lézard4d
The Cigna Group announces leadership changes to accelerate the company's growth strategy
BLOOMFIELD, Conn., March 13, 2025 /PRNewswire/ -- The Cigna Group (NYSE: CI), a global health company, today announced leadership changes designed to further drive the company's focus on customers and ...